Powder: -20°C for 3 years | In solvent: -80°C for 1 year
CA-4948 (Emavusertib) 是一种IRAK4抑制剂,也是一种FLT3抑制剂,具有抗肿瘤作用。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 283 | 现货 | ||
2 mg | ¥ 393 | 现货 | ||
5 mg | ¥ 598 | 现货 | ||
10 mg | ¥ 789 | 现货 | ||
25 mg | ¥ 1,550 | 现货 | ||
50 mg | ¥ 2,890 | 现货 | ||
100 mg | ¥ 4,280 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 678 | 现货 |
产品描述 | CA-4948 (Emavusertib) is a potent IRAK4/FLT3 inhibtor. CA-4948 with anti-tumor activity. |
体外活性 | CA-4948, demonstrated good cellular activity in ABC DLBCL and AML cell lines.?Inhibition of TLR signaling leading to decreased IL-6 levels was also observed in whole blood assays.?CA-4948 demonstrated moderate to high selectivity in a panel of 329 kinases as well as exhibited desirable ADME and PK profiles including good oral bioavailability in mice, rat, and dog and showed >90% tumor growth inhibition in relevant tumor models with excellent correlation with in vivo PD modulation.?CA-4948 was well tolerated in toxicity studies in both mouse and dog at efficacious exposure.?The overall profile of CA-4948 prompted us to select it as a clinical candidate for evaluation in patients with relapsed or refractory hematologic malignancies including non-Hodgkin lymphoma and acute myeloid leukemia[2]. |
别名 | Emavusertib |
分子量 | 491.5 |
分子式 | C24H25N7O5 |
CAS No. | 1801344-14-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: < 0.1 mg/mL (insoluble)
DMSO: 27.78 mg/mL (56.52 mM), Sonication is recommended.
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 2.0346 mL | 10.1729 mL | 20.3459 mL | 50.8647 mL |
5 mM | 0.4069 mL | 2.0346 mL | 4.0692 mL | 10.1729 mL | |
10 mM | 0.2035 mL | 1.0173 mL | 2.0346 mL | 5.0865 mL | |
20 mM | 0.1017 mL | 0.5086 mL | 1.0173 mL | 2.5432 mL | |
50 mM | 0.0407 mL | 0.2035 mL | 0.4069 mL | 1.0173 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
CA-4948 1801344-14-8 Angiogenesis Immunology/Inflammation NF-Κb Tyrosine Kinase/Adaptors IRAK FLT rheumatoid inflammation CD135 inhibit IL-1R associated kinase CA4948 lymphoma Interleukin-1 receptor associated kinase Fms like tyrosine kinase 3 Emavusertib FLT3 arthritis Inhibitor Cluster of differentiation antigen 135 Myd88 CA 4948 IL-1R Toll inhibitor